We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.14B
AUM Growth
+$218M
Cap. Flow
+$172M
Cap. Flow %
8.07%
Top 10 Hldgs %
26.01%
Holding
154
New
13
Increased
61
Reduced
17
Closed
10

Top Buys

Rank Stock Value
1
GTT
GTT Communications, Inc.
GTT
+$19.7M
2
ANET icon
Arista Networks
ANET
+$17.8M
3
VRNS icon
Varonis Systems
VRNS
+$17.3M
4
ROP icon
Roper Technologies
ROP
+$16.3M
5
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$15.9M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$16.9M
2
TWLO icon
Twilio
TWLO
+$7.85M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.12M
4
LOXO
Loxo Oncology, Inc
LOXO
+$5.96M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$5.72M

Sector Composition

Rank Sector Weight
1 Healthcare 38.18%
2 Technology 17.61%
3 Consumer Discretionary 12.18%
4 Industrials 9.62%
5 Utilities 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM
101
DELISTED
Dermira, Inc.
DERM
$2.67M 0.13%
334,000
+210,000
+169% +$4.57M
INCY icon
102
Incyte
INCY
$26.3B
$2.58M 0.12%
31,000
+4,000
+15% +$361K
ACAD icon
103
Acadia Pharmaceuticals
ACAD
$4.44B
$2.55M 0.12%
113,600
-221,100
-66% -$6.12M
DLPH
104
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$2.51M 0.12%
52,666
– –
FRTX
105
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$2.46M 0.12%
5,397
– –
NGNE icon
106
Neurogene
NGNE
$656M
$2.46M 0.12%
8,750
– –
FHB icon
107
First Hawaiian
FHB
$3.41B
$2.46M 0.12%
88,500
+15,400
+21% +$448K
ACRS icon
108
Aclaris Therapeutics
ACRS
$740M
$2.45M 0.11%
140,000
– –
JCI icon
109
Johnson Controls International
JCI
$85.8B
$2.34M 0.11%
66,500
+14,000
+27% +$532K
ABB
110
DELISTED
ABB Ltd
ABB
$2.25M 0.11%
95,000
+19,700
+26% +$507K
RARX
111
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.06M 0.1%
+388,000
New +$2.77M
HMC icon
112
Honda
HMC
$39.1B
$2.05M 0.1%
59,000
+4,650
+9% +$164K
SYRS
113
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.95M 0.09%
15,000
– –
SEP
114
DELISTED
Spectra Engy Parters Lp
SEP
$1.85M 0.09%
55,000
-7,500
-12% -$299K
PTCT icon
115
PTC Therapeutics
PTCT
$6.29B
$1.84M 0.09%
68,200
– –
EPIX
116
DELISTED
ESSA Pharma
EPIX
$1.83M 0.09%
481,971
+346,000
+254% +$1.44M
TSM icon
117
TSMC
TSM
$2.05T
$1.82M 0.09%
41,500
+3,000
+8% +$131K
FPRX
118
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.8M 0.08%
105,000
-210,000
-67% -$4.1M
TERP
119
DELISTED
TerraForm Power, Inc
TERP
$1.73M 0.08%
161,000
+57,700
+56% +$650K
BDN
120
Brandywine Realty Trust
BDN
$521M
$1.64M 0.08%
103,500
+22,000
+27% +$366K
BG icon
121
Bunge Global
BG
$22.8B
$1.6M 0.08%
21,700
+3,400
+19% +$257K
TSRO
122
DELISTED
TESARO, Inc.
TSRO
$1.49M 0.07%
26,000
– –
TNDM icon
123
Tandem Diabetes Care
TNDM
$1.21B
$1.36M 0.06%
+275,000
New +$887K
ETN icon
124
Eaton
ETN
$150B
$1.36M 0.06%
17,000
+4,300
+34% +$353K
PRTA icon
125
Prothena Corp
PRTA
$443M
$1.36M 0.06%
37,000
-83,000
-69% -$3.02M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Eventide Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Eventide Asset Management held 154 positions worth $2.14B, up 11% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $172M of net new capital in Q1 2018, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Arista Networks: 1,056,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Trade Desk, an estimated $16.9M trimmed.

  • Eventide Asset Management's largest Q1 2018 buy was Arista Networks: 1,056,000 shares worth $16.9M.
  • Eventide Asset Management added most to GTT Communications, Inc. in Q1 2018, an estimated $19.7M increase.
  • Eventide Asset Management's biggest Q1 2018 reduction was Trade Desk, cutting an estimated $16.9M.
  • Eventide Asset Management fully exited Protagonist Therapeutics in Q1 2018, selling an estimated $5.72M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $2.14B portfolio in Q1 2018.
  • Eventide Asset Management opened 13 new positions and closed 10 in Q1 2018.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $2.14B.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.